The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
|Articles|March 27, 2023
Switzerland Approves Study Examining Effects of Controlled Purchases of Cannabis
Author(s)Erin McEvoy
The study will examine consumption and health of the participants after purchasing selected cannabis products from controlled cultivation under regulated conditions.
Advertisement
On March 21, 2023, the study titled “Züri Can–Cannabis with responsibility,” created by the City of Zurich and the University of Zurich, met approval and opened its registration process, after being postponed in 2022. “The study examines the effects of purchasing selected cannabis products from controlled cultivation under regulated conditions on the consumption and health of the participants,” read the study, translated from German (1). “In addition, different models of regulated cannabis procurement are to be compared with one another.”
The sale of cannabis products for the study will begin at the preestablished supply points after the summer holidays, and only organic and local products will be permitted (1). Currently, cannabis products containing less than 1% THC are permitted in Switzerland under limited instances (2).
“As a study participant, you will contribute to research into a possible regulation of cannabis consumption in Switzerland,” read the consent form in part, translated from German (3). “If you meet the eligibility requirements below and are included in the study, you can legally purchase cannabis for personal use for three years under regulated conditions. As a study participant, you must fill out a scientific online questionnaire at regular intervals.”
Scientific, approved pilot trials of controlled sales of cannabis for recreational purposes were first allowed in 2021 (4). Future studies with public and university sponsors are planned for several more cities in Switzerland (1).
References
https://www.stadt-zuerich.ch/portal/de/index/politik_u_recht/stadtrat/weitere-politikfelder/drogen-suchtpolitik/studien-und-projekte/cannabisprojekt-der-stadt-zuerich/wissenswertes-zur-cannabis-studie.html https://www.ch.ch/en/health/medicines-and-narcotic-substances/cannabis/#when-is-cannabis-an-illegal-drug https://www.stadt-zuerich.ch/portal/de/index/politik_u_recht/stadtrat/weitere-politikfelder/drogen-suchtpolitik/studien-und-projekte/cannabisprojekt-der-stadt-zuerich/konsumierende.html https://www.stadt-zuerich.ch/portal/de/index/politik_u_recht/stadtrat/weitere-politikfelder/drogen-suchtpolitik/studien-und-projekte/cannabisprojekt-der-stadt-zuerich.html#
Advertisement
Related to this article
Curaleaf is opening a new cannabis dispensary called Curaleaf Millcreek in Erie, Pennsylvania.
Learn how third-party audits enhance compliance in the cannabis industry, ensuring readiness for evolving regulations and fostering consumer trust.
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
A lack of standards for cannabis vape devices puts consumers at risk, but several organizations are committed to the research, collaboration, and solutions needed to promote safety and quality in the industry.
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!
Advertisement
Advertisement